Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Non-small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02706392
What this trial is testing

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more
Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00113516
What this trial is testing

SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 84
Testing effectiveness (Phase 2)Ended earlyNCT02846792
What this trial is testing

Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer

Who this might be right for
ALK Gene TranslocationEGFR Activating MutationRecurrent Non-Small Cell Lung Carcinoma+3 more
University of Washington 5
Large-scale testing (Phase 3)Active Not RecruitingNCT03787992
What this trial is testing

Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer （FLAG）

Who this might be right for
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer
Allist Pharmaceuticals, Inc. 358
Testing effectiveness (Phase 2)WithdrawnNCT03023904
What this trial is testing

Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00365547
What this trial is testing

Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 46
Testing effectiveness (Phase 2)Ended earlyNCT04069936
What this trial is testing

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

Who this might be right for
Non Small Cell Lung CancerLung CancerLung Cancer Metastatic+5 more
WindMIL Therapeutics 19
Not applicableStudy completedNCT01740804
What this trial is testing

Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungCell, Circulating Tumor
Guangdong Association of Clinical Trials 180
Testing effectiveness (Phase 2)UnknownNCT05132777
What this trial is testing

Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung CancerEGFR Exon20 Insertion Mutations
Shanghai JMT-Bio Inc. 155
Testing effectiveness (Phase 2)Study completedNCT00087412
What this trial is testing

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungLarge Cell Lung CancerRecurrent Non-small Cell Lung Cancer+3 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT03319628
What this trial is testing

First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b

Who this might be right for
Platinum Resistant Ovarian CancerNon Small Cell Lung Cancer Metastatic
Mersana Therapeutics 523
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)Study completedNCT05146219
What this trial is testing

Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation

Who this might be right for
NSCLCEGFR Activating MutationBrain Metastases+1 more
TYK Medicines, Inc 29
Not applicableUnknownNCT03481101
What this trial is testing

WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC

Who this might be right for
Non Small Cell Lung CancerCirculating Tumor CellCirculating Tumor DNA
Rigshospitalet, Denmark 60
Not applicableStudy completedNCT01999881
What this trial is testing

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

Who this might be right for
Extensive Stage Small Cell Lung CancerHealthy, no Evidence of DiseaseLimited Stage Small Cell Lung Cancer+9 more
University of Wisconsin, Madison 21
Large-scale testing (Phase 3)Ended earlyNCT01041781
What this trial is testing

Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 313
Testing effectiveness (Phase 2)Looking for participantsNCT06581419
What this trial is testing

A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant NeoplasmAdvanced or Metastatic Non-small Cell Lung Cancer
SUNHO（China）BioPharmaceutical CO., Ltd. 78
Not applicableUnknownNCT04778800
What this trial is testing

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Who this might be right for
NSCLCBrain MetastasesLeptomeningeal Metastasis
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06929936
What this trial is testing

Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerMyelosuppression
The First Affiliated Hospital of Xiamen University 33
Testing effectiveness (Phase 2)UnknownNCT04560244
What this trial is testing

A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment

Who this might be right for
Non-Small-Cell Lung Cancer
Shandong Cancer Hospital and Institute 15
Next Page